Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Affiliations

¹ The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
³ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
⁴ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA.
⁵ Sage Bionetworks, 1100 Fairview Ave. N., Seattle, Washington, 98109, USA.
⁶ Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA.
⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
⁸ Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA.
⁹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
¹⁰ Howard Hughes Medical Institute, Chevy Chase, Maryland, 20815, USA.
¹¹ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA. robert.schlegel@novartis.com.
¹² The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA. Levi_Garraway@dfci.harvard.edu.
¹³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
¹⁴ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.

^# Contributed equally.

Published Erratum

Jordi Barretina et al. Nature. 2019 Jan.

. 2019 Jan;565(7738):E5-E6.

doi: 10.1038/s41586-018-0722-x.

¹ The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
³ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
⁴ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA.
⁵ Sage Bionetworks, 1100 Fairview Ave. N., Seattle, Washington, 98109, USA.
⁶ Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA.
⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
⁸ Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA.
⁹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
¹⁰ Howard Hughes Medical Institute, Chevy Chase, Maryland, 20815, USA.
¹¹ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA. robert.schlegel@novartis.com.
¹² The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA. Levi_Garraway@dfci.harvard.edu.
¹³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
¹⁴ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.

^# Contributed equally.

No abstract available

Erratum for

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jané-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA. Barretina J, et al. Nature. 2012 Mar 28;483(7391):603-7. doi: 10.1038/nature11003. Nature. 2012. PMID: 22460905 Free PMC article.

1. The Cancer Cell Line Encyclopedia Consortium & The Genomics of Drug Sensitivity in Cancer Consortium. Pharmacogenomic agreement between two cancer cell line data sets. Nature 528, 84–87 (2015).